Simplifying the injector's armamentarium: An international consensus regarding the use of gel science to differentiate hyaluronic acid fillers and guide treatment recommendations
Andrei Metelitsa,Kaitlyn M. Enright,Frank Rosengaus,Luiz Avelar,Stephanie Lam,Philippe Berros,Carlo Di Gregorio,Sabrina Fabi,Firas Hamdan,Steven Liew,Kuldeep Minocha,Rungsima Wanitphakdeedecha,Steven Weiner,Andreas Nikolis
DOI: https://doi.org/10.1111/jocd.16207
2024-02-07
Journal of Cosmetic Dermatology
Abstract:Background The Restylane portfolio of soft tissue fillers spans a wide range of indications, due in part to their complementary manufacturing technologies [non‐animal stabilized hyaluronic acid (NASHA) and Optimal Balance Technology (OBT/XpresHAn)]. Using an array of products, injectors can achieve a holistic, natural looking effect for their patients. However, with a wide range of products it may be difficult to choose an optimal combination. Aim Simplify and align global use recommendations for NASHA versus OBT products. Methods Two pre‐meeting surveys were completed by 11 key opinion leaders with international representation, with the goal of collecting information regarding their current injection practices for various anatomical regions of the face (i.e., temporal region, forehead, tear trough, lateral zygoma, anteromedial cheek, nose, pyriform aperture, nasolabial fold, perioral area, lips, labiomental crease, marionette lines, chin, and jawline). The data collected from these surveys was subsequently discussed in a consensus group meeting involving 11 voting members and 3 nonvoting members. Results Top product recommendations were identified for each anatomical area, along with secondary and tertiary recommendations that can also be used under defined circumstances. Recommendations were provided based on a consideration of elements such as patient features (e.g., skin thickness, bone structure), the desired aesthetic outcome, experience of the injector, and the preferred injection technique. Conclusion A majority consensus regarding the top NASHA versus OBT product choice for each anatomical region of the face was reached. These recommendations represent international agreement regarding the use of Restylane products.
dermatology